Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Shares Outstanding (Diluted Average) (2021 - 2025)

HeartSciences filings provide 5 years of Shares Outstanding (Diluted Average) readings, the most recent being $2.8 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 203.07% to $2.8 million in Q4 2025 year-over-year; TTM through Oct 2025 was $2.8 million, a 203.07% increase, with the full-year FY2025 number at $938257.0, up 166.16% from a year prior.
  • Shares Outstanding (Diluted Average) hit $2.8 million in Q4 2025 for HeartSciences, up from $1.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $7.4 million in Q1 2023 to a low of $79506.0 in Q2 2023.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $1.1 million (2025), compared with a mean of $2.3 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): tumbled 98.42% in 2023 and later surged 735.25% in 2024.
  • HeartSciences' Shares Outstanding (Diluted Average) stood at $3.3 million in 2021, then skyrocketed by 109.27% to $6.9 million in 2022, then tumbled by 98.42% to $109841.0 in 2023, then surged by 735.25% to $917445.0 in 2024, then soared by 203.07% to $2.8 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $2.8 million (Q4 2025), $1.3 million (Q3 2025), and $938257.0 (Q2 2025) per Business Quant data.